유리체 탐포네이드 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2034년)

Vitreous Tamponades Market - Scope of Report

TMR's report on the global vitreous tamponades market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global vitreous tamponades market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global vitreous tamponades market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the vitreous tamponades market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global vitreous tamponades market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global vitreous tamponades market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global vitreous tamponades market.

The report delves into the competitive landscape of the global vitreous tamponades market. Key players operating in the global vitreous tamponades market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global vitreous tamponades market profiled in this report.

Key Questions Answered in Global vitreous tamponades Market Report:

• What is the sales/revenue generated by vitreous tamponades across all regions during the forecast period?
• What are the opportunities in the global vitreous tamponades market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2034?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Vitreous Tamponades Market - Research Objectives and Research Approach

The comprehensive report on the global vitreous tamponades market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global vitreous tamponades market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global vitreous tamponades market.

Table of Contents

1. Preface

• 1.1. Market Definition and Scope
• 1.2. Market Segmentation
• 1.3. Key Research Objectives
• 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Vitreous Tamponades Market

4. Market Overview

• 4.1. Introduction
  • 4.1.1. Product Type Definition
  • 4.1.2. Industry Evolution/Developments
• 4.2. Overview
• 4.3. Market Dynamics
  • 4.3.1. Drivers
  • 4.3.2. Restraints
  • 4.3.3. Opportunities
• 4.4. Global Vitreous Tamponades Market Analysis and Forecast, 2017 - 2031

5. Key Insights

• 5.1. Pipeline Analysis
• 5.2. Key Product Type/Brand Analysis
• 5.3. Key Mergers & Acquisitions
• 5.4. COVID-19 Pandemic Impact on Industry

6. Global Vitreous Tamponades Market Analysis and Forecast, by Product Type

• 6.1. Introduction & Definition
• 6.2. Key Findings/Developments
• 6.3. Market Value Forecast, by Product Type, 2017 - 2031
  • 6.3.1. Gaseous Tamponades
  • 6.3.2. Liquid Tamponades
    • 6.3.2.1. Silicone Oil
    • 6.3.2.2. Perfluorocarbon Liquids
• 6.4. Market Attractiveness Analysis, by Product Type

7. Global Vitreous Tamponades Market Analysis and Forecast, by End-user

• 7.1. Introduction & Definition
• 7.2. Key Findings/Developments
• 7.3. Market Value Forecast, by End-user, 2017 - 2031
  • 7.3.1. Hospitals
  • 7.3.2. Ophthalmology Clinics
• 7.4. Market Attractiveness Analysis, by End-user

8. Global Vitreous Tamponades Market Analysis and Forecast, by Region

• 8.1. Key Findings
• 8.2. Market Value Forecast, by Region, 2017 - 2031
  • 8.2.1. North America
  • 8.2.2. Europe
  • 8.2.3. Asia Pacific
  • 8.2.4. Latin America
  • 8.2.5. Middle East & Africa
• 8.3. Market Attractiveness Analysis, by Region

9. North America Vitreous Tamponades Market Analysis and Forecast

• 9.1. Introduction
• 9.2. Key Findings
• 9.3. Market Value Forecast, by Product Type, 2017 - 2031
  • 9.3.1. Gaseous Tamponades
  • 9.3.2. Liquid Tamponades
    • 9.3.2.1. Silicone Oil
    • 9.3.2.2. Perfluorocarbon Liquids
• 9.4. Market Value Forecast, by End-user, 2017 - 2031
  • 9.4.1. Hospitals
  • 9.4.2. Ophthalmology Clinics
• 9.5. Market Value Forecast, by Country, 2017 - 2031
  • 9.5.1. U.S.
  • 9.5.2. Canada
• 9.6. Market Attractiveness Analysis
  • 9.6.1. By Product Type
  • 9.6.2. By End-user
  • 9.6.3. By Country

10. Europe Vitreous Tamponades Market Analysis and Forecast

• 10.1. Introduction
• 10.2. Key Findings
• 10.3. Market Value Forecast, by Product Type, 2017 - 2031
  • 10.3.1. Gaseous Tamponades
  • 10.3.2. Liquid Tamponades
    • 10.3.2.1. Silicone Oil
    • 10.3.2.2. Perfluorocarbon Liquids
• 10.4. Market Value Forecast, by End-user, 2017 - 2031
  • 10.4.1. Hospitals
  • 10.4.2. Ophthalmology Clinics
• 10.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
  • 10.5.1. Germany
  • 10.5.2. U.K.
  • 10.5.3. France
  • 10.5.4. Italy
  • 10.5.5. Spain
  • 10.5.6. Rest of Europe
• 10.6. Market Attractiveness Analysis
  • 10.6.1. By Product Type
  • 10.6.2. By End-user
  • 10.6.3. By Country/Sub-region

11. Asia Pacific Vitreous Tamponades Market Analysis and Forecast

• 11.1. Introduction
• 11.2. Key Findings
• 11.3. Market Value Forecast, by Product Type, 2017 - 2031
  • 11.3.1. Gaseous Tamponades
  • 11.3.2. Liquid Tamponades
    • 11.3.2.1. Silicone Oil
    • 11.3.2.2. Perfluorocarbon Liquids
• 11.4. Market Value Forecast, by End-user, 2017 - 2031
  • 11.4.1. Hospitals
  • 11.4.2. Ophthalmology Clinics
• 11.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
  • 11.5.1. China
  • 11.5.2. Japan
  • 11.5.3. India
  • 11.5.4. Australia & New Zealand
  • 11.5.5. Rest of Asia Pacific
• 11.6. Market Attractiveness Analysis
  • 11.6.1. By Product Type
  • 11.6.2. By End-user
  • 11.6.3. By Country/Sub-region

12. Latin America Vitreous Tamponades Market Analysis and Forecast

• 12.1. Introduction
• 12.2. Key Findings
• 12.3. Market Value Forecast, by Product Type, 2017 - 2031
  • 12.3.1. Gaseous Tamponades
  • 12.3.2. Liquid Tamponades
    • 12.3.2.1. Silicone Oil
    • 12.3.2.2. Perfluorocarbon Liquids
• 12.4. Market Value Forecast, by End-user, 2017 - 2031
  • 12.4.1. Hospitals
  • 12.4.2. Ophthalmology Clinics
• 12.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
  • 12.5.1. Brazil
  • 12.5.2. Mexico
  • 12.5.3. Rest of Latin America
• 12.6. Market Attractiveness Analysis
  • 12.6.1. By Product Type
  • 12.6.2. By End-user
  • 12.6.3. By Country/Sub-region

13. Middle East & Africa Vitreous Tamponades Market Analysis and Forecast

• 13.1. Introduction
• 13.2. Key Findings
• 13.3. Market Value Forecast, by Product Type, 2017 - 2031
  • 13.3.1. Gaseous Tamponades
  • 13.3.2. Liquid Tamponades
    • 13.3.2.1. Silicone Oil
    • 13.3.2.2. Perfluorocarbon Liquids
• 13.4. Market Value Forecast, by End-user, 2017 - 2031
  • 13.4.1. Hospitals
  • 13.4.2. Ophthalmology Clinics
• 13.5. Market Value Forecast, by Country/Sub-region, 2017 - 2031
  • 13.5.1. GCC Countries
  • 13.5.2. South Africa
  • 13.5.3. Rest of Middle East & Africa
• 13.6. Market Attractiveness Analysis
  • 13.6.1. By Product Type
  • 13.6.2. By End-user
  • 13.6.3. By Country/Sub-region

14. Competition Landscape

• 14.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
• 14.2. Market Share Analysis, by Company (2022)
• 14.3. Company Profiles
  • 14.3.1. Fluoron GmbH
    • 14.3.1.1. Company Overview
    • 14.3.1.2. Product Type Portfolio
    • 14.3.1.3. SWOT Analysis
    • 14.3.1.4. Financial Overview
    • 14.3.1.5. Strategic Overview
  • 14.3.2. Carl Zeiss Meditec AG
    • 14.3.2.1. Company Overview
    • 14.3.2.2. Product Type Portfolio
    • 14.3.2.3. SWOT Analysis
    • 14.3.2.4. Financial Overview
    • 14.3.2.5. Strategic Overview
  • 14.3.3. D.O.R.C Dutch Ophthalmic Research Center International B.V.
    • 14.3.3.1. Company Overview
    • 14.3.3.2. Product Type Portfolio
    • 14.3.3.3. SWOT Analysis
    • 14.3.3.4. Financial Overview
    • 14.3.3.5. Strategic Overview
  • 14.3.4. Alchimia Srl
    • 14.3.4.1. Company Overview
    • 14.3.4.2. Product Type Portfolio
    • 14.3.4.3. SWOT Analysis
    • 14.3.4.4. Financial Overview
    • 14.3.4.5. Strategic Overview
  • 14.3.5. Bausch Health Companies, Inc.
    • 14.3.5.1. Company Overview
    • 14.3.5.2. Product Type Portfolio
    • 14.3.5.3. SWOT Analysis
    • 14.3.5.4. Financial Overview
    • 14.3.5.5. Strategic Overview
  • 14.3.6. Novartis AG
    • 14.3.6.1. Company Overview
    • 14.3.6.2. Product Type Portfolio
    • 14.3.6.3. SWOT Analysis
    • 14.3.6.4. Financial Overview
    • 14.3.6.5. Strategic Overview